VIH1.DEVIH1.DEXETRA
Loading
Revenue Growth Under PressureDecelerating
Percentile Rank31
Year-over-Year Change
Year-over-year revenue growth rate
Latest
0.00%
↓ 100% vs avg
Percentile
P31
Within normal range
Streak
1 qtr
Consecutive growthDecelerating
Average
7.31%
Historical baseline
| Period | Value |
|---|---|
| Q2 2025 | 0.00% |
| Q1 2025 | -51.01% |
| Q4 2024 | 110.14% |
| Q3 2024 | 18.48% |
| Q2 2024 | 0.00% |
| Q1 2024 | -53.05% |
| Q4 2023 | 114.54% |
| Q3 2023 | -56.65% |
| Q2 2023 | 108.00% |
| Q1 2023 | -53.39% |
| Q4 2022 | 114.52% |
| Q3 2022 | 3.81% |
| Q2 2022 | -1.83% |
| Q1 2022 | 0.40% |
| Q4 2021 | -0.95% |
| Q3 2021 | 2.68% |
| Q2 2021 | 4.80% |
| Q1 2021 | 3.99% |
| Q4 2020 | -0.69% |
| Q3 2020 | 4.34% |
| Q2 2020 | -1.88% |
| Q1 2020 | 3.26% |
| Q4 2019 | -2.33% |
| Q3 2019 | 2.93% |
| Q2 2019 | 0.20% |
| Q1 2019 | 0.37% |
| Q4 2018 | 3.03% |
| Q3 2018 | 2.16% |
| Q2 2018 | 0.28% |
| Q1 2018 | -1.31% |
| Q4 2017 | 3.15% |
| Q3 2017 | 0.67% |
| Q2 2017 | 1.77% |
| Q1 2017 | -2.75% |
| Q4 2016 | 6.99% |
| Q3 2016 | 0.42% |
| Q2 2016 | 0.07% |
| Q1 2016 | -3.39% |
| Q4 2015 | 7.65% |
| Q3 2015 | 2.83% |